Sign in with Google. Opens in new tab
ENTITY
Genscript Biotech

Genscript Biotech (1548 HK)

79
Analysis
Health CareHong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
13 Nov 2024 05:10

StubWorld: Hanwha Corp; Genscript Biotech/Legend Biotech

Hanwha Corp appears attractive here. The pushback is that HC is thinly traded. And Genscript’s  deconsolidation has minimal impact on financials...

Logo
348 Views
Share
25 Jul 2024 08:04

StubWorld: Legend (LEGN US) Offer Or Not, Genscript (1548 HK) Is Attractive

Genscript appears attractive - not just Legend's product pipeline and strong partnerships; but also Genscript's stub ops have been performing well....

Logo
428 Views
Share
20 Jul 2022 01:03

2022H2 China Healthcare Investment Strategy and Top Picks

We analyze the investment strategy,top picks and logic in CXO,pharmaceuticals and medical device industry.As a “defensive sector”,China healthcare...

Logo
491 Views
Share
30 Jun 2025 00:55

Pre-IPO China Medical System (867 HK) - About the IPO in Singapore and Concerns on Valuation Outlook

Listing in SGX opens a new chapter and CMS is undergoing pipeline adjustments and strategic transformation. But as valuation logic changes, license...

Logo
274 Views
Share
29 Jun 2025 01:19

China Healthcare Weekly (Jun.29) - Biotech Valuation Bubble Is About to Burst, Innovent's Placement

The valuation bubble of innovative drug companies may burst soon, with some founders/shareholders already cashing out. Innovent's Placing Price of...

Logo
286 Views
Share
x